| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/30/2005 | CN1194747C Medicament for peptic ulcer and chronic gastritis and preparation thereof |
| 03/30/2005 | CN1194736C Composition for treating hepatitis B |
| 03/30/2005 | CN1194734C Pill for treating hepatitis B |
| 03/30/2005 | CN1194728C Pellet capable of curing infantile anorexia and convulsion |
| 03/30/2005 | CN1194722C Shugan Zhitong soft extract for treating hepatitis |
| 03/30/2005 | CN1194713C Medicine for resisting senility, shrinking vagina, beautifying breast and stregthening male genitals and its production method |
| 03/30/2005 | CN1194703C Health-care food for protecting gastric mucosa and its preparing process |
| 03/30/2005 | CN1194695C Adfuwei ester soft capsule and its preparation method |
| 03/30/2005 | CN1194684C Maltilate emulsion and preparation proless thereof |
| 03/30/2005 | CN1194683C Silymarin behenic acid glyceride lipid nano particle oral solution dosage and its preparation method |
| 03/30/2005 | CN1194678C Tiopronin freeze-dried powder injection |
| 03/30/2005 | CN1194676C Use of amfetamine alcohol compounds as medicine for treating hepatitis B and preparation method thereof |
| 03/30/2005 | CN1194675C Use of trans-3, 4, 5-trihydroxy-diphenyl in preparation of medicine for resisting hepatitis B virus |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872805 Hepatitis C virus inhibitors |
| 03/29/2005 | US6872749 Administering to the cow salt of ester of methionine, an ester of methionine amide, and an ester of the hydroxy analogue of methionine |
| 03/29/2005 | US6872743 Antiinflammatory agents; sepsis shock; antiarthritic agents |
| 03/29/2005 | US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/29/2005 | US6872735 LFA-1 antagonist compounds |
| 03/29/2005 | US6872731 Imidazo-pyridine derivatives as ligands for GABA receptors |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/29/2005 | US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione |
| 03/29/2005 | US6872719 Antiinflammatory agents; autoimmune disease |
| 03/29/2005 | US6872714 Methods to modulate conditions mediated by the CXCR4 receptor |
| 03/29/2005 | US6872565 Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries |
| 03/29/2005 | US6872391 Nucleotide sequences coding polypeptide for use in the treatment of eating disorders |
| 03/29/2005 | CA2335186C Pyrrolo[2,3-d]pyrimidine compounds |
| 03/29/2005 | CA2280447C Pyrrolo¬1,2-a|pyrazine derivatives as 5ht1a ligands |
| 03/29/2005 | CA2268870C Heterocyclic carboxamides |
| 03/29/2005 | CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/29/2005 | CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/29/2005 | CA2108699C Method of purification of amylase, purified amylase so obtained and uses of purified amylase |
| 03/24/2005 | WO2005026173A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same |
| 03/24/2005 | WO2005026164A1 Pharmacologically active imidazo[4,5-c]pyridines |
| 03/24/2005 | WO2005025605A1 Remedy and therapeutic method for periodontal diseases and pulpal diseases |
| 03/24/2005 | WO2005025596A1 Glatiramer acetate for use as an immuno-modulatory agent |
| 03/24/2005 | WO2005025580A1 Use of n-acetyl-d-aminoglycosamine in preparation of drugs for modulating microorganisms on mucous membrane |
| 03/24/2005 | WO2005025577A1 Use of ciclesonide for the treatment of inflammatory bowel diseases |
| 03/24/2005 | WO2005025574A2 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 03/24/2005 | WO2005025520A2 Chitosan spinning method, device therefor, and resulting chitosan yarn, and uses thereof |
| 03/24/2005 | WO2005009331A3 Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 03/24/2005 | WO2004112505A8 Use of isomalt (mixture of 1,6 gps and 1,1 gpm) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things |
| 03/24/2005 | WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065328 Gastrokines and derived peptides including inhibitors |
| 03/24/2005 | US20050065327 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065186 Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/24/2005 | US20050065140 Antidepressant; side effect reduction |
| 03/24/2005 | US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents |
| 03/24/2005 | US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors |
| 03/24/2005 | US20050065112 Antiproliferative agents; low toxicity; psoriasis; antitumor agents; rheumatic arthritis; gastrointestinal disorders; antiinflamamtory agents |
| 03/24/2005 | US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents |
| 03/24/2005 | US20050065097 Liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 03/24/2005 | US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064453 Kit which utilizes interleukin-1-related gene as diagnostic/prognostic tool in detection of urogenital disorders; genomics and bioinformatics |
| 03/24/2005 | US20050063980 An alginate, a pectin and an antacid, such as sodium or potassium bicarbonate; gastrointestinal reflux disease |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063922 Dental restorative materials |
| 03/24/2005 | US20050063917 Solid oral compositions |
| 03/24/2005 | DE102004042021A1 Use of chitin, chitosan or their derivatives for prophylactic and therapeutic purposes in agricultural livestock production |
| 03/24/2005 | CA2539286A1 Use of n-acetyl-d-aminoglycosamine in preparation of drugs for modulating microorganisms on mucous membrane |
| 03/24/2005 | CA2538843A1 Animal model for protease activity and liver damage |
| 03/24/2005 | CA2538202A1 Use of ciclesonide for the treatment of inflammatory bowel diseases |
| 03/24/2005 | CA2537695A1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1516878A1 Refreshment capable of stimulating movement of digestive tract |
| 03/23/2005 | EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto |
| 03/23/2005 | EP1516866A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 03/23/2005 | EP1516623A1 Drug for prevention and/or treatment of constipation and symptom caused by constipation |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1515978A1 Sulfur-containing phospholipid derivatives |
| 03/23/2005 | EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/23/2005 | EP1515968A2 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 03/23/2005 | EP1515963A2 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| 03/23/2005 | EP1515961A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 03/23/2005 | EP1515959A1 Pharmaceutical salts of reboxetine |
| 03/23/2005 | EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 03/23/2005 | EP1515942A1 Carboxamides derivatives |
| 03/23/2005 | EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 03/23/2005 | EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515731A1 Anti-spasmodic comprising xenon |
| 03/23/2005 | EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 03/23/2005 | EP1515722A2 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 03/23/2005 | EP1515718A2 Modulation of activation of glucocorticoid receptors by breakdown products of glucocorticoids |
| 03/23/2005 | EP1515708A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 03/23/2005 | EP1100469B1 Rapidly disintegrable solid preparation |
| 03/23/2005 | EP1089733B1 Use of optically pure (+)-norcisapride for treating irritable bowel syndrome |
| 03/23/2005 | EP1045832B1 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 03/23/2005 | EP1032398B1 Treating postmenopausal women using ultra-low doses of estrogen |
| 03/23/2005 | EP1027064B1 A process for the removal of undersired toxic alkaloids from plants or from vegetable preparations |
| 03/23/2005 | CN1599750A Cytotoxic protein and utilization thereof |
| 03/23/2005 | CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 03/23/2005 | CN1599741A Thioether substituted imidazoquinolines |
| 03/23/2005 | CN1599740A Amide substituted imidazopyridines |